These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12107641)
1. Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer? Thier R; Brüning T; Roos PH; Bolt HM Arch Toxicol; 2002 Jun; 76(5-6):249-56. PubMed ID: 12107641 [TBL] [Abstract][Full Text] [Related]
2. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067 [TBL] [Abstract][Full Text] [Related]
3. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524 [TBL] [Abstract][Full Text] [Related]
4. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. Harth V; Schafer M; Abel J; Maintz L; Neuhaus T; Besuden M; Primke R; Wilkesmann A; Thier R; Vetter H; Ko YD; Bruning T; Bolt HM; Ickstadt K J Toxicol Environ Health A; 2008; 71(13-14):887-97. PubMed ID: 18569591 [TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer. Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Roos PH; Bolt HM Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):187-202. PubMed ID: 16922636 [TBL] [Abstract][Full Text] [Related]
7. Statistical methods for detecting genetic interactions: a head and neck squamous-cell cancer study. Ickstadt K; Schäfer M; Fritsch A; Schwender H; Abel J; Bolt HM; Brüning T; Ko YD; Vetter H; Harth V J Toxicol Environ Health A; 2008; 71(11-12):803-15. PubMed ID: 18569579 [TBL] [Abstract][Full Text] [Related]
8. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746 [TBL] [Abstract][Full Text] [Related]
9. Gene-environment interactions in determining differences in genetic susceptibility to cancer in subsites of the head and neck. Maurya SS; Katiyar T; Dhawan A; Singh S; Jain SK; Pant MC; Parmar D Environ Mol Mutagen; 2015 Apr; 56(3):313-21. PubMed ID: 25399842 [TBL] [Abstract][Full Text] [Related]
10. [Role of metabolic polymorphisms in lung carcinogenesis]. Kiyohara C; Ohno Y Nihon Koshu Eisei Zasshi; 1999 Apr; 46(4):241-9. PubMed ID: 10491856 [TBL] [Abstract][Full Text] [Related]
11. Influence of the Cyp1B1 L432V gene polymorphism and exposure to tobacco smoke on Cyp1B1 mRNA expression in human leukocytes. Helmig S; Hadzaad B; Döhrel J; Schneider J Drug Metab Dispos; 2009 Jul; 37(7):1490-5. PubMed ID: 19349377 [TBL] [Abstract][Full Text] [Related]
12. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Oude Ophuis MB; van Lieshout EM; Roelofs HM; Peters WH; Manni JJ Cancer; 1998 Mar; 82(5):936-43. PubMed ID: 9486585 [TBL] [Abstract][Full Text] [Related]
13. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380 [TBL] [Abstract][Full Text] [Related]
14. CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50,000 individuals. Kaur-Knudsen D; Nordestgaard BG; Tybjaerg-Hansen A; Bojesen SE Pharmacogenet Genomics; 2009 Sep; 19(9):685-94. PubMed ID: 19730035 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility. McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460 [TBL] [Abstract][Full Text] [Related]
17. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer. Shah PP; Singh AP; Singh M; Mathur N; Mishra BN; Pant MC; Parmar D Mutat Res; 2008 Aug; 643(1-2):4-10. PubMed ID: 18573508 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in catalase and CYP1B1 determine DNA adduct formation by benzo(a)pyrene ex vivo. Schults MA; Chiu RK; Nagle PW; Wilms LC; Kleinjans JC; van Schooten FJ; Godschalk RW Mutagenesis; 2013 Mar; 28(2):181-5. PubMed ID: 23325794 [TBL] [Abstract][Full Text] [Related]
19. Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke. Georgiadis P; Demopoulos NA; Topinka J; Stephanou G; Stoikidou M; Bekyrou M; Katsouyianni K; Sram R; Autrup H; Kyrtopoulos SA Toxicol Lett; 2004 Apr; 149(1-3):269-80. PubMed ID: 15093273 [TBL] [Abstract][Full Text] [Related]
20. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis. Economopoulos KP; Sergentanis TN Breast Cancer Res Treat; 2010 Jul; 122(2):545-51. PubMed ID: 20054638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]